Blood contacting medical devices are those devices that come in contact with blood during diagnosis, treatment, or surgery. Medical devices such as cardiovascular devices, dialysis devices, catheters, and implantable devices come in contact with blood. Most blood contacting devices are implantable, and they help in the normal functioning of vital organs. The specific surface modification requirement of a blood contacting device depends on the time span that the device will be in contact with blood. Blood contacting medical devices are made of synthetic materials. When blood comes in contact with these materials that are foreign to the body, a number of adverse reactions are initiated. These reactions include platelet activation, platelet attachment, and complement activation. They eventually lead to clot formation and fibrin production. Thrombus development is a common cause of failure of blood contacting medical devices. This is because artificial biomaterials endorse clotting through a complex series of connected processes that include adhesion of platelets, protein adsorption, leukocytes and thrombin generation, and red blood cells and complement activation.
Factors such as the risk of contamination of blood contacting device during or after the treatment and cost of these devices is likely to hamper the global market for blood contacting devices.
The global blood contacting medical devices market can be segmented based on product, application, end-user, and region. Based on product, the global blood contacting medical devices market can be categorized into short-term blood contacting devices, long-term blood contacting devices, and implantable blood contacting devices. Short-term blood contacting devices are introducers or catheters that also need a lubricious surface. Antiadherent blood-compatible coverings are often hydrogels that are lubricious when wet. Therefore, they can concurrently provide the dual surface developments of hemocompatibility and lubricity. Long-term blood contacting devices, such as cardiovascular devices, are used to assist various heart failure conditions. The most common blood contacting cardiovascular device is the stent. Stents are used for opening an artery that is blocked by growth of plaque. They help keep the coronary arteries open, thus reducing the risk of heart attacks. There are different types of stents such as bare metal stents, drug eluting stents, and bioresorbable stents. The implantable blood contacting devices segment can be further categorized into orthopedic implantable devices, cardiovascular implantable devices, and other medical implantable devices. In terms of applications, the global blood contacting medical devices market can be categorized into spine surgery, gynecological surgery, orthopedic surgery, neurological surgery, urological surgery, and other surgeries. Based on end-user, the global blood contacting medical devices market can be categorized into hospitals, specialty clinics, ambulatory surgery centers, and others.
In terms of geography, the blood contacting medical devices market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global blood contacting medical devices market, due to the availability of better treatment options and rapid change in lifestyle. Moreover, a rise in the number of individuals undergoing treatment for life threatening diseases and better reimbursement facilities are expected to augment the market in the region. Europe is a prominent region of the blood contacting medical devices market. The blood contacting medical devices market in Asia Pacific is expected to be driven by the presence of local players in the market in the region, increase in prevalence of life threatening diseases such as cardiovascular disorders, and increase in organ failure.
Some of the key players operating in blood contacting medical devices market are SynCardia Systems, LLC, Berlin Heart, HeartWare, Lifetech Scientific, Abbott, Boston Scientific Corporation, and Medtronic.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.